Drivers Varian Medical
DUBLIN--(BUSINESS WIRE)--The 'Global Radiotherapy Market Analysis, Companies Profiles, Size, Share, Growth, Trends and Forecast to 2024' report has been added to Research and Markets' offering.
In this report, global radiotherapy market is projected to reach USD 9.3 billion by 2024 from USD 5.2 billion in 2016, at a CAGR of 7.5% in the forecast period 2017 to 2024.
A technical analyst looks at the history of Varian Medical trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. As of the 26th of December, Varian Medical has the Standard Deviation of 0.1695, risk adjusted performance of 0.1109, and Downside Deviation of 0.1561. In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Varian Medical Systems, as well as the relationship between them. Varex Imaging Completes Separation from Varian Medical Systems, Lists on the Nasdaq Stock Market 01/30/17 SALT LAKE CITY, Utah, January 30, 2017 – Varex Imaging Corporation (Nasdaq: VREX) today announced that its spin-off from Varian Medical Systems (NYSE: VAR) has been successfully completed.
Scope of the Report
Drivers Varian Medical Stock
- The global radiotherapy market is segmented into three types, namely beam radiotherapy, brachytherapy and systematic radiotherapy.
- Radiotherapy market is segmented into beam radiotherapy, brachytherapy and systematic radiotherapy.
- The beam radiotherapy is segmented into IGRT, IMRT, VMAT, tomotherapy, stereotactic technology and 3D conformal technology.
- The brachytherapy is segmented into LDR and HDR.
- On the basis of product type, the market is segmented into external beam radiotherapy, internal radiotherapy products, radiotherapy software and systematic radiotherapy.
- External beam radiotherapy is segmented into LINAC, CyberKnife, proton therapy and Gamma Knife.
- The proton beam is segmented into cyclotron and synclotron. The internal beam is segmented into seeds and afterloaders.
- The radiotherapy software is segmented into treatment planning softwares, dosage planning softwares, patient positioning software and image guiding softwares.
- On the basis of indication, the market is segmented into prostate cancer, breast cancer, lung cancer, spine cancer, liver cancer, brain cancer and others.
Market Overview
Drivers
- Growing Prevalence of Cancer
- Rising Ageing Population
- Unhealthy Lifestyle
- Mergers and Acquisitions to Expand Business
Restraints
- Regulatory Scenario
- High Cost of Radiotherapy
Opportunities
- Growing Medical Tourism in Asia
- Emerging Market
Challenges
- Side-Effects of Radiotherapy
- Requirement of Trained Staff
Global radiotherapy market competition by top players including:
Varian Medical Systems, Inc. dominated the radiotherapy market followed by Elekta AB, and Accuray, Inc. along with others
- CIVCO Medical Solutions
- Brainlab AG
- C. R. Bard, Inc.
- IsoRay Medical, Inc.
- Nordion, Inc.
- RaySearch Laboratories AB
- PRECISIS AG
- Mevion Medical Systems, Inc.
- TechnicasRadiofiscas S.L.
- Hitachi, Ltd.
- Sumitomo Heavy Industries, Ltd.
- Mitsubishi Electric Corporation
- ProNova Solutions, LLC
- ProTom International
Key Topics Covered:
1. Introduction
2. Market Segmentation
3. Market Overview
4. Executive Summary
5. Premium Insights
6. Global Radiotherapy Market, by Therapy Type
7. Global Radiotherapy Market, by Product Type
8. Global Radiotherapy Market, by Indication
9. Multi-monitor usb mouse hid driver download. Global Radiotherapy Market, by Geography
10. Global Radiotherapy Market, Company Share
11. Company Profiles
- Accuray, Inc.
- Brainlab AG
- C. R. Bard, Inc.
- CIVCO Medical Solutions
- Elekta AB,
- Hitachi, Ltd.
- IsoRay Medical, Inc.
- Mevion Medical Systems, Inc.
- Mitsubishi Electric Corporation
- Nordion, Inc.
- PRECISIS AG
- ProNova Solutions, LLC
- ProTom International
- RaySearch Laboratories AB
- Sumitomo Heavy Industries, Ltd.
- TechnicasRadiofiscas S.L.
- Varian Medical Systems, Inc.
For more information about this report visit https://www.researchandmarkets.com/research/483p8l/global
Drivers Varian Medical
About Research and Markets
Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Varian Medical (NYSE:VAR), known for its use of rfxcel serialization software , said today it launched an FDA-cleared version of its Velocity cancer imaging software, including a new Rapidsphere module.
The newly launched Velocity 4.0’s Rapidsphere module is designed for Y90 selective internal radiation therapy dosimetry analysis and provides improved information on tumor responses and normal-tissue toxicity for patients undergoing SIRT, the Palo Alto, Calif.-based company said.
Drivers qualcomm atheros input devices usb. The Velocity 4.0 software includes the company’s Velocity M3i multi-modality motion imaging component, the Velocity Aria sync component and the Velocity tumor & dose tracking component.
Varian Medical Utah
“At Varian, we are focused on providing clinicians with powerful and comprehensive solutions that enable them to provide personalized cancer therapy for patients. Patient-specific 3D imaging and dosimetry for targeted cancer therapy delivery is important for predicting the tumor’s response to therapy. The Rapidsphere module is a significant advancement for interventional radiologists performing Y90 SIRT,” Varian oncology systems biz prez Kolleen Kennedy said in a press release.
Drivers Varian Medical Company
Last week, Brainlab said it inked a deal with Varian looking to support interoperability between Brainlab’s ExacTrac and Varian’s Clinac platform, TrueBeam and Edge systems.